TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations August 31, 2001
TCL Archive New Technology May Enable Therapy Tailored To Patient’s Predicted Response April 26, 2002